Weighing the Benefits of “Watchful Waiting”

Groundbreaking, three-part coverage of AdMeTech’s research program in prostate MRI and its potential impact on screening, diagnosis and treatment by the Wall Street Journal.
Part I

You’ve been getting annual blood tests to check for prostate cancer. But two big studies in the New England Journal of Medicine just found that screening for PSA — prostate specific antigen — doesn’t save many lives. Should you keep checking it?

Your biopsy was negative for prostate cancer but your PSA keeps rising. Should you stop worrying — or have another biopsy?

Read More